Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.

PubWeight™: 0.82^‹?›

🔗 View Article (PMID 25962395)

Published in Oncol Rep on April 28, 2015

Authors

Jun Zhou¹, Guanghui Gong¹, Hong Tan¹, Furong Dai², Xin Zhu², Yile Chen³, Junpu Wang¹, Ying Liu¹, Puxiang Chen⁴, Xiaoying Wu¹, Jifang Wen¹

Author Affiliations

1: Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan 410013, P.R. China.
2: Department of Gynecology and Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
3: Department of Gynecology Oncology, Hunan Tumor Hospital, Changsha, Hunan 410013, P.R. China.
4: Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.

Articles citing this ↘

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int J Mol Sci (2016) 0.86

Clinical relevance of circulating cell-free microRNAs in ovarian cancer. Mol Cancer (2016) 0.83

Exosomes: Potential in Cancer Diagnosis and Therapy. Medicines (Basel) (2015) 0.80

miR-203 Expression in Exfoliated Cells of Tongue Coating Represents a Sensitive and Specific Biomarker of Gastroesophageal Reflux Disease. Gastroenterol Res Pract (2016) 0.75

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer. Mol Cancer (2017) 0.75

miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLoS One (2017) 0.75

Articles by these authors ⇆

miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. Int J Oncol (2015) 0.80

MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells. Oncol Rep (2015) 0.78